Thyme Care closed $95M in a Series C round led by Concord Health Partners and Banc of California to fuel cancer care affordability.

Jul 16, 2024•over 1 year ago

Amount Raised

$95 Million

Round Type

series c

NashvilleHealth Care

Investors

Banc Of CaliforniaForesite CapitalFrist Cressey VenturesEcho Health VenturesAlley CorpA16z Bio + HealthTown Hall VenturesCvs Health VenturesConcord Health Partners

Description

Thyme Care, the leading value-based cancer care enabler, announced the close of a $95M capital raise, with $55M in equity funding and an additional $40M in debt financing.

Company Information

Company

Thyme Care

Location

10 Lea Avenue, Suite 760

Nashville, Tennessee, United States

About

Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers, and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with more than 800 oncologists in Thyme Care Oncology Partners, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX, and is backed by leading investors.

Related People

4 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends